Market

Ocular Therapeutix stock price target raised to $24 from $17 at RBC Capital

Ocular Therapeutix stock price target raised to $24 from $17 at RBC Capital
Read More

Related Posts

Form 6K Cementos Pacasmayo SAA ADR For: 5 December

Form 6K Cementos Pacasmayo SAA ADR For: 5 December

What does Netflix’s offer to buy HBO Max mean for you?

What does Netflix’s offer to buy HBO Max mean for you?

Raykov Rosty sells Fennec Pharmaceuticals (FENC) shares for $75,400

Raykov Rosty sells Fennec Pharmaceuticals (FENC) shares...

BioLife Solutions (BLFS) CFO Wichterman sells $771,600 in stock

BioLife Solutions (BLFS) CFO Wichterman sells $771,600 ...

Treasury market logs worst weekly rout since April, in a bad sign for borrowers

Treasury market logs worst weekly rout since April, in ...

Enanta Pharma CBO Luu sells $19,836 in stock

Enanta Pharma CBO Luu sells $19,836 in stock